Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Astrid Tschan‐Plessl, A."'
Autor:
Jeroen S. Goede, Christa K. Baumann, Richard Cathomas, Nina Khanna, Jean-Francois Lambert, Thomas Lehmann, Ulrich J. M. Mey, Jörg Seebach, Urs C. Steiner, Astrid Tschan-Plessl, Frank Stenner
Publikováno v:
Swiss Medical Weekly, Vol 154, Iss 9 (2024)
Immunoglobulins for intravenous use (IVIgs) and subcutaneous use (SCIgs) can prevent recurrent and severe infections in patients with secondary antibody deficiencies that are frequently linked to haematological/oncological malignancies as well as oth
Externí odkaz:
https://doaj.org/article/8740b918b44a46adbecb48308fcd8252
Autor:
M. Heuser, W. Fiedler, A. Block, D. C. de Leeuw, A. van de Loosdrecht, A. Astrid Tschan-Plessl, J. Passweg, A. Kloos, A. Schwarzer, L. Venturini, A. D. Duru, K. Pinkernell, A. Ganser
Publikováno v:
HemaSphere, Vol 6, Pp 1338-1339 (2022)
Externí odkaz:
https://doaj.org/article/714f9e90bf4e441eb8207447e1e6ed30
Autor:
Andreas Holbro, Dominik Heim, Astrid Tschan-Plessl, Katharina Baur, Jörg P. Halter, Andreas Buser, Jakob R. Passweg
Publikováno v:
Therapeutische Umschau. 76:542-548
Zusammenfassung. Die Transfusionsmedizin und die allogene Stammzelltransplantation gehören im Bereich der Hämatologie zu den bekannten und etablierten zellulären Therapien. Seit Jahrzehnten versucht man das patienteneigene Immunsystem so umzuprogr
Autor:
Dominik Heim, Beatrice Drexler, Maria Martinez, Dimitrios A. Tsakiris, Astrid Tschan-Plessl, Tobias Andreas Buser, Jakob Passweg
Publikováno v:
European Journal of Haematology. 103:472-477
Introduction In this study, we analyzed the changes of thrombin generation as marker of coagulation activation and von Willebrand factor (vWF) levels as a marker of endothelial activation in patients undergoing chemotherapy, autologous, or allogeneic
Autor:
Ebba, Sohlberg, Aline, Pfefferle, Eivind, Heggernes Ask, Astrid, Tschan-Plessl, Benedikt, Jacobs, Herman, Netskar, Susanne, Lorenz, Minoru, Kanaya, Mizuha, Kosugi-Kanaya, Stephan, Meinke, Anette, Mörtberg, Petter, Höglund, Mikael, Sundin, Göran, Carlsson, Jan, Palmblad, Karl-Johan, Malmberg
Publikováno v:
Blood. 139(5)
Neutrophils have been thought to play a critical role in terminal differentiation of NK cells. Whether this effect is direct or a consequence of global immune changes with effects on NK-cell homeostasis remains unknown. In this study, we used high-re
Autor:
Eivind Heggernes, Ask, Astrid, Tschan-Plessl, Thea Johanne, Gjerdingen, Michelle Lu, Sætersmoen, Hanna Julie, Hoel, Merete Thune, Wiiger, Johanna, Olweus, Björn E, Wahlin, Ole Christian, Lingjærde, Amir, Horowitz, Amanda F, Cashen, Marcus, Watkins, Todd A, Fehniger, Harald, Holte, Arne, Kolstad, Karl-Johan, Malmberg
Publikováno v:
Med (New York, N.Y.). 2(2)
Current prognostic variables can only partly explain the large outcome heterogeneity in diffuse large B cell lymphoma (DLBCL). We aimed to investigate the utility of systems-level protein and immune repertoire profiling for outcome prognostication in
Autor:
Andreas, Holbro, Dominik, Heim, Astrid, Tschan-Plessl, Katharina, Baur, Jörg P, Halter, Andreas, Buser, Jakob R, Passweg
Publikováno v:
Therapeutische Umschau. Revue therapeutique. 76(9)
Cellular therapies
Autor:
Jan Palmblad, Mikael Sundin, Astrid Tschan-Plessl, Goran Karlsson, Ebba Sohlberg, Petter Höglund, Karl-Johan Malmberg, Benedikt Jacobs, Aline Pfefferle, Suzanne Lorenz, Stephan Meinke, Eivind Heggernes Ask
Publikováno v:
Blood. 136:24-25
Neutrophils are innate cells that have been suggested to play a critical role in terminal differentiation of NK cells. Whether this is a direct effect or a consequence of global immune changes with effects on NK cell homeostasis remains unknown. Here
Autor:
Merete Thune Wiiger, Björn E. Wahlin, Astrid Tschan-Plessl, Todd A. Fehniger, Thea Johanne Gjerdingen, Eivind Heggernes Ask, Arne Kolstad, Johanna Olweus, Amir Horowitz, Hanna Julie Hoel, Harald Holte, Karl-Johan Malmberg, Michelle L. Saetersmoen
Publikováno v:
Blood. 134:2897-2897
Global gene expression profiling of the tumor microenvironment in diffuse large B-cell lymphoma (DLBCL) has revealed broad innate immune signatures that distinguish the heterogeneous disease subtypes and correlate with good treatment outcome. However